\-\ Texto\\:\\ \ \(0\)\
\-\ no\\ laboratory\\ data\\.\ \(1\)\
\-\ patient\\ was\\ referred\\ to\\ orthopedics\\ for\\ possible\\ radiofrequency\\ ablation\\ therapy\\.\ \(0\)\
\-\ ap\\ view\\ of\\ the\\ lumbosarcral\\ spine\\ showing\\ an\\ enlarged\\ right\\ l4\\ pedicle\\ in\\ comparison\\ with\\ the\\ left\\.\\ also\\,\\ mild\\ dextrothoracic\\ and\\ levolumbar\\ scoliosis\\ is\\ present\\.\ \(0\)\
\-\ the\\ \\ oblique\\ view\\ of\\ the\\ lumbosacral\\ spine\\ showing\\ an\\ enlarged\\ right\\ pedicle\\ with\\ sclerotic\\ margin\\.\ \(0\)\
\-\ sagittal\\ ct\\ image\\ of\\ lumbar\\ spine\\ showing\\ a\\ sclerotic\\ lesion\\ in\\ the\\ right\\ l4\\ pedicle\\ with\\ central\\ nidus\\.\ \(0\)\
\-\ the\\ coronal\\ image\\ of\\ ct\\ lumbar\\ spine\\ showing\\ \\ a\\ sclerotic\\ lesion\\ in\\ the\\ right\\ l4\\ pedicle\\ with\\ central\\ nidus\\.\ \(0\)\
\-\ osteoid\\ osteoma\ \(14\)\
\-\ \\â\\€\\¢\\ osteoblastoma\ \(1\)\
\-\ \\â\\€\\¢\\ brodie\\ abscess\ \(0\)\
\-\ \\â\\€\\¢\\ sclerotic\\ metastases\ \(0\)\
\-\ \\â\\€\\¢\\ osteoma\ \(2\)\
\-\ \\â\\€\\¢\\ osteogenic\\ sarcoma\ \(0\)\
\-\ \\â\\€\\¢\\ lymphoma\ \(6\)\
\-\ this\\ eleven\\ year\\ old\\ girl\\ has\\ scoliosis\\ and\\ is\\ complaining\\ of\\ low\\ back\\ pain\\.\ \(0\)\
\-\ osteoid\\ osteoma\\ is\\ a\\ benign\\ skeletal\\ neoplasm\\ of\\ unknown\\ etiology\\.\\ the\\ tumor\\ consists\\ of\\ an\\ ovoid\\ or\\ spherical\\ nidus\\ of\\ osteoid\\-rich\\ tissue\\ and\\ interconnected\\ bone\\ trabeculae\\ superimposed\\ on\\ a\\ background\\ of\\ highly\\ vascularized\\ connective\\ tissue\\ containing\\ large\\ dilated\\ vascular\\ channels\\.the\\ average\\ size\\ of\\ the\\ nidus\\ is\\ approximately\\ 1\\.5\\ cm\\,\\ but\\ its\\ size\\ can\\ be\\ 0\\.5\\-2\\ cm\\.\\ \\ the\\ tumor\\ is\\ usually\\ smaller\\ than\\ 1\\.5\\ cm\\ in\\ diameter\\.\\ osteoid\\ osteoma\\ can\\ occur\\ in\\ any\\ bone\\,\\ but\\ in\\ approximately\\ two\\ thirds\\ of\\ patients\\,\\ the\\ appendicular\\ skeleton\\ is\\ involved\\.\\ the\\ skull\\ and\\ facial\\ bones\\ are\\ involved\\ exceptionally\\.\ \(0\)\
\-\ osteoid\\ osteoma\\ more\\ commonly\\ affects\\ males\\ than\\ females\\.\\ the\\ male\\-to\\-female\\ ratio\\ is\\ 2\\:1\\.most\\ patients\\ with\\ osteoid\\ osteoma\\ are\\ young\\ with\\ three\\ quarters\\ of\\ patients\\ are\\ aged\\ 10\\-30\\ years\\,and\\ more\\ than\\ 90\\%\\ of\\ patients\\ are\\ aged\\ 5\\-25\\ years\\.\ \(0\)\
\-\ the\\ classic\\ presentation\\ includes\\ focal\\ skeletal\\ bone\\ pain\\,\\ which\\ worsens\\ at\\ night\\ and\\ is\\ frequently\\ relieved\\ with\\ a\\ small\\ dose\\ of\\ aspirin\\.\\ pain\\ that\\ increases\\ with\\ activity\\ and\\ at\\ night\\ occurs\\ in\\ 95\\%\\ of\\ patients\\ with\\ spinal\\ tumors\\.\\ in\\ 29\\%\\ of\\ patients\\,\\ the\\ pain\\ is\\ severe\\ enough\\ to\\ waken\\ the\\ patient\\.\\ the\\ site\\ of\\ involvement\\ may\\ be\\ tender\\ to\\ touch\\ or\\ pressure\\.\\ constitutional\\ symptoms\\ are\\ usually\\ absent\\.\ \(0\)\
\-\ when\\ the\\ spinal\\ column\\ is\\ involved\\,\\ muscle\\ spasms\\ may\\ cause\\ abnormal\\ alignment\\.\\ a\\ painful\\ scoliosis\\ may\\ be\\ concave\\ toward\\ the\\ lesion\\.\\ the\\ onset\\ of\\ scoliosis\\ may\\ be\\ acute\\ and\\ is\\ frequently\\ initiated\\ by\\ physical\\ exertion\\.\\ osteoid\\ osteoma\\ has\\ been\\ called\\ the\\ most\\ common\\ cause\\ of\\ painful\\ scoliosis\\.\ \(0\)\
\-\ radiography\\ is\\ the\\ initial\\ examination\\ of\\ choice\\ and\\ may\\ be\\ the\\ only\\ examination\\ required\\.\\ the\\ lesion\\ initially\\ appears\\ as\\ a\\ small\\ sclerotic\\ bone\\ island\\ within\\ a\\ circular\\ lucent\\ defect\\.\\ this\\ central\\ nidus\\ is\\ seldom\\ larger\\ than\\ 1\\.5\\ cm\\ in\\ diameter\\,\\ and\\ it\\ may\\ be\\ associated\\ with\\ considerable\\ overlying\\ cortical\\ and\\ endosteal\\ bone\\ sclerosis\\.\\ ct\\ is\\ used\\ for\\ precise\\ localization\\.\\ mri\\ is\\ a\\ useful\\ imaging\\ technique\\,\\ but\\ ct\\ appears\\ superior\\ for\\ precise\\ localization\\.\\ radionuclide\\ scanning\\ for\\ technetium\\-99m\\ diphosphonate\\ uptake\\ shows\\ fairly\\ intense\\ activity\\ at\\ the\\ tumor\\ site\\.\\ radionuclide\\ scanning\\ is\\ a\\ sensitive\\ technique\\,\\ and\\ findings\\ may\\ be\\ positive\\ before\\ radiographic\\ changes\\ are\\ apparent\\.\ \(0\)\
\-\ for\\ the\\ treatment\\ of\\ osteoid\\ osteoma\\ surgery\\,\\ conservative\\ treatment\\ with\\ nonsteroidal\\ anti\\-inflammatory\\ medications\\,\\ and\\ radiofrequency\\ ablation\\ are\\ potential\\ options\\.\\ surgery\\ is\\ frequently\\ associated\\ with\\ major\\ morbidity\\ and\\ a\\ prolonged\\ period\\ of\\ recovery\\.\\ longterm\\ drug\\ therapy\\ may\\ result\\ in\\ gastrointestinal\\ side\\ effects\\ and\\ is\\ not\\ well\\ tolerated\\ by\\ patients\\.\\ percutaneous\\ rf\\ ablation\\ is\\ performed\\ under\\ ct\\ guidance\\ by\\ using\\ general\\ or\\ spinal\\ anesthesia\\.24\\ after\\ localization\\ of\\ the\\ nidus\\ with\\ 1\\-\\ to\\ 3\\-mm\\ ct\\ sections\\,\\ an\\ osseous\\ access\\ is\\ established\\ with\\ either\\ a\\ 2\\-mm\\ coaxial\\ drill\\ system\\ or\\ an\\ 11\\-gauge\\ jamshidi\\ needle\\.\\ radiofrequency\\ ablation\\ is\\ performed\\ at\\ 90\\Â\\°c\\ for\\ 4\\-5\\ minutes\\ by\\ using\\ a\\ rigid\\ rf\\ electrode\\ with\\ a\\ 1\\-mm\\ diameter\\.\\ the\\ procedure\\ is\\ successful\\ when\\ the\\ electrode\\ is\\ heated\\ to\\ the\\ desired\\ temperature\\ within\\ the\\ nidus\\.\\ in\\ one\\ series\\,\\ clinical\\ success\\ was\\ achieved\\ in\\ 96\\%\\ of\\ patients\\.\\ all\\ recurrences\\ were\\ treated\\ with\\ a\\ second\\ procedure\\,\\ with\\ a\\ secondary\\ success\\ rate\\ of\\ 100\\%\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ osteoid\\:\\ 0\\.2908848027459227\ \(0\)\
\-\ osteoma\\:\\ 0\\.27896002662274955\ \(0\)\
\-\ nidus\\:\\ 0\\.26385334738963356\ \(0\)\
\-\ the\\:\\ 0\\.21057522295062722\ \(0\)\
\-\ is\\:\\ 0\\.20772409420612978\ \(0\)\
\-\ scoliosis\\:\\ 0\\.18266595194498134\ \(0\)\
\-\ of\\:\\ 0\\.16134537837451113\ \(0\)\
\-\ pedicle\\:\\ 0\\.1507733413655049\ \(0\)\
\-\ patients\\:\\ 0\\.1484192576090005\ \(0\)\
\-\ ablation\\:\\ 0\\.14412059312089462\ \(0\)\
\-\ sclerotic\\:\\ 0\\.13832510884698856\ \(0\)\
\-\ radiofrequency\\:\\ 0\\.1341771805621988\ \(0\)\
\-\ may\\:\\ 0\\.13276798101216775\ \(0\)\
\-\ showing\\:\\ 0\\.11389968927077944\ \(0\)\
\-\ localization\\:\\ 0\\.11308000602412868\ \(0\)\
\-\ with\\:\\ 0\\.10978041189575753\ \(0\)\
\-\ and\\:\\ 0\\.10222013646386059\ \(0\)\
\-\ in\\:\\ 0\\.09844881342827266\ \(0\)\
\-\ electrode\\:\\ 0\\.09488595262003316\ \(0\)\
\-\ l4\\:\\ 0\\.09445928468917\ \(0\)\
\-\ be\\:\\ 0\\.09364740949725127\ \(0\)\
\-\ bone\\:\\ 0\\.08997144447172403\ \(0\)\
\-\ are\\:\\ 0\\.08759781813030679\ \(0\)\
\-\ spine\\:\\ 0\\.0871431277487309\ \(0\)\
\-\ precise\\:\\ 0\\.08383768493613568\ \(0\)\
\-\ frequently\\:\\ 0\\.08147649492417583\ \(0\)\
\-\ radionuclide\\:\\ 0\\.08073583581724585\ \(0\)\
\-\ diameter\\:\\ 0\\.07951463045105328\ \(0\)\
\-\ involved\\:\\ 0\\.07933011794985455\ \(0\)\
\-\ rf\\:\\ 0\\.0788566823585028\ \(0\)\
\-\ cm\\:\\ 0\\.07576051252300393\ \(0\)\
\-\ ct\\:\\ 0\\.07533214884462928\ \(0\)\
\-\ than\\:\\ 0\\.07477909161057007\ \(0\)\
\-\ aged\\:\\ 0\\.07206029656044731\ \(0\)\
\-\ scanning\\:\\ 0\\.0717434911441754\ \(0\)\
\-\ success\\:\\ 0\\.07143513488747395\ \(0\)\
\-\ spinal\\:\\ 0\\.07025149765361809\ \(0\)\
\-\ technique\\:\\ 0\\.06803293967802064\ \(0\)\
\-\ central\\:\\ 0\\.06606878015801168\ \(0\)\
\-\ lesion\\:\\ 0\\.0632431788823511\ \(0\)\
\-\ an\\:\\ 0\\.06305500927018796\ \(0\)\
\-\ for\\:\\ 0\\.05997381949638845\ \(0\)\
\-\ skeletal\\:\\ 0\\.05979377954384014\ \(0\)\
\-\ night\\:\\ 0\\.059250831239576716\ \(0\)\
\-\ painful\\:\\ 0\\.058333486324495885\ \(0\)\
\-\ by\\:\\ 0\\.056018930989901856\ \(0\)\
\-\ using\\:\\ 0\\.05424863218605791\ \(0\)\
\-\ lumbar\\:\\ 0\\.05325976714423061\ \(0\)\
\-\ site\\:\\ 0\\.053196755138925154\ \(0\)\
\-\ lumbosarcral\\:\\ 0\\.052740361984831445\ \(0\)\
\-\ dextrothoracic\\:\\ 0\\.052740361984831445\ \(0\)\
\-\ levolumbar\\:\\ 0\\.052740361984831445\ \(0\)\
\-\ interconnected\\:\\ 0\\.052740361984831445\ \(0\)\
\-\ quarters\\:\\ 0\\.052740361984831445\ \(0\)\
\-\ waken\\:\\ 0\\.052740361984831445\ \(0\)\
\-\ jamshidi\\:\\ 0\\.052740361984831445\ \(0\)\
\-\ 90\\:\\ 0\\.052704652176611785\ \(0\)\
\-\ procedure\\:\\ 0\\.05258483064468168\ \(0\)\
\-\ tumor\\:\\ 0\\.05174955719240272\ \(0\)\
\-\ coaxial\\:\\ 0\\.05039623148060143\ \(0\)\
\-\ at\\:\\ 0\\.04982611783056058\ \(0\)\
\-\ to\\:\\ 0\\.04946788755422672\ \(0\)\
\-\ but\\:\\ 0\\.04892427980002803\ \(0\)\
\-\ longterm\\:\\ 0\\.048733044419448854\ \(0\)\
\-\ drill\\:\\ 0\\.048733044419448854\ \(0\)\
\-\ heated\\:\\ 0\\.048733044419448854\ \(0\)\
\-\ activity\\:\\ 0\\.04842500875436592\ \(0\)\
\-\ view\\:\\ 0\\.04830090014576452\ \(0\)\
\-\ appears\\:\\ 0\\.04830090014576452\ \(0\)\
\-\ pain\\:\\ 0\\.04720418595987644\ \(0\)\
\-\ eleven\\:\\ 0\\.04638891391521884\ \(0\)\
\-\ exceptionally\\:\\ 0\\.04638891391521884\ \(0\)\
\-\ or\\:\\ 0\\.0458910198712084\ \(0\)\
\-\ vascularized\\:\\ 0\\.04549771685878933\ \(0\)\
\-\ enlarged\\:\\ 0\\.04496424352001811\ \(0\)\
\-\ cause\\:\\ 0\\.04493345076052033\ \(0\)\
\-\ seldom\\:\\ 0\\.04472572685406627\ \(0\)\
\-\ nonsteroidal\\:\\ 0\\.04472572685406627\ \(0\)\
\-\ size\\:\\ 0\\.044659945053973416\ \(0\)\
\-\ right\\:\\ 0\\.04373541430326287\ \(0\)\
\-\ brodie\\:\\ 0\\.04343565874463399\ \(0\)\
\-\ desired\\:\\ 0\\.04343565874463399\ \(0\)\
\-\ spasms\\:\\ 0\\.042884638458608876\ \(0\)\
\-\ diphosphonate\\:\\ 0\\.042884638458608876\ \(0\)\
\-\ worsens\\:\\ 0\\.04238159634983625\ \(0\)\
\-\ rigid\\:\\ 0\\.04238159634983625\ \(0\)\
\-\ recurrences\\:\\ 0\\.04238159634983625\ \(0\)\
\-\ examination\\:\\ 0\\.04220664017286608\ \(0\)\
\-\ image\\:\\ 0\\.04218237432060699\ \(0\)\
\-\ approximately\\:\\ 0\\.042085816979883\ \(0\)\
\-\ island\\:\\ 0\\.04191884246806784\ \(0\)\
\-\ circular\\:\\ 0\\.04191884246806784\ \(0\)\
\-\ usually\\:\\ 0\\.04152281696230651\ \(0\)\
\-\ concave\\:\\ 0\\.04149039929340674\ \(0\)\
\-\ osteogenic\\:\\ 0\\.04109152824040397\ \(0\)\
\-\ years\\:\\ 0\\.04043118852455527\ \(0\)\
\-\ spherical\\:\\ 0\\.04003746584560624\ \(0\)\
\-\ when\\:\\ 0\\.03984226834525968\ \(0\)\
\-\ trabeculae\\:\\ 0\\.03972488500911957\ \(0\)\
\-\ considerable\\:\\ 0\\.03914626878917672\ \(0\)\
\-\ performed\\:\\ 0\\.03902079169580361\ \(0\)\
\-\ appendicular\\:\\ 0\\.03862033026561035\ \(0\)\
\-\ thirds\\:\\ 0\\.03837427878445366\ \(0\)\
\-\ sections\\:\\ 0\\.03837427878445366\ \(0\)\
\-\ aspirin\\:\\ 0\\.03791152490268525\ \(0\)\
\-\ therapy\\:\\ 0\\.037896977413161795\ \(0\)\
\-\ constitutional\\:\\ 0\\.03769333534137623\ \(0\)\
\-\ osteoblastoma\\:\\ 0\\.03748308172802415\ \(0\)\
\-\ superimposed\\:\\ 0\\.03728020697614452\ \(0\)\
\-\ endosteal\\:\\ 0\\.03728020697614452\ \(0\)\
\-\ background\\:\\ 0\\.037084210675021385\ \(0\)\
\-\ guidance\\:\\ 0\\.037084210675021385\ \(0\)\
\-\ access\\:\\ 0\\.0368946416532471\ \(0\)\
\-\ achieved\\:\\ 0\\.0368946416532471\ \(0\)\
\-\ tolerated\\:\\ 0\\.03671109172330109\ \(0\)\
\-\ more\\:\\ 0\\.03621783286963365\ \(0\)\
\-\ initiated\\:\\ 0\\.036030148280223655\ \(0\)\
\-\ skeleton\\:\\ 0\\.0358717455720877\ \(0\)\
\-\ 96\\:\\ 0\\.0358717455720877\ \(0\)\
\-\ orthopedics\\:\\ 0\\.035567394398455236\ \(0\)\
\-\ established\\:\\ 0\\.035567394398455236\ \(0\)\
\-\ surgery\\:\\ 0\\.03546165013443457\ \(0\)\
\-\ alignment\\:\\ 0\\.035421023613868806\ \(0\)\
\-\ morbidity\\:\\ 0\\.035421023613868806\ \(0\)\
\-\ enough\\:\\ 0\\.03513895122379414\ \(0\)\
\-\ column\\:\\ 0\\.03500291348427987\ \(0\)\
\-\ lumbosacral\\:\\ 0\\.03487000332784369\ \(0\)\
\-\ associated\\:\\ 0\\.03476465491594574\ \(0\)\
\-\ relieved\\:\\ 0\\.034613012700227756\ \(0\)\
\-\ increases\\:\\ 0\\.034613012700227756\ \(0\)\
\-\ exertion\\:\\ 0\\.034613012700227756\ \(0\)\
\-\ fairly\\:\\ 0\\.034613012700227756\ \(0\)\
\-\ can\\:\\ 0\\.034612512268805046\ \(0\)\
\-\ tissue\\:\\ 0\\.034599923618288085\ \(0\)\
\-\ average\\:\\ 0\\.034366961219071075\ \(0\)\
\-\ most\\:\\ 0\\.0343263852317869\ \(0\)\
\-\ connective\\:\\ 0\\.03424775416736462\ \(0\)\
\-\ effects\\:\\ 0\\.03424775416736462\ \(0\)\
\-\ small\\:\\ 0\\.034023203878380884\ \(0\)\
\-\ males\\:\\ 0\\.03401646983901032\ \(0\)\
\-\ affects\\:\\ 0\\.0337940832995287\ \(0\)\
\-\ toward\\:\\ 0\\.0337940832995287\ \(0\)\
\-\ radiography\\:\\ 0\\.033686017775993636\ \(0\)\
\-\ temperature\\:\\ 0\\.03357993521841141\ \(0\)\
\-\ females\\:\\ 0\\.03317406072763053\ \(0\)\
\-\ ratio\\:\\ 0\\.033076893109638794\ \(0\)\
\-\ ovoid\\:\\ 0\\.03288732408786451\ \(0\)\
\-\ consists\\:\\ 0\\.03279482071956412\ \(0\)\
\-\ gastrointestinal\\:\\ 0\\.032525872823613675\ \(0\)\
\-\ sensitive\\:\\ 0\\.03243893378411515\ \(0\)\
\-\ recovery\\:\\ 0\\.03243893378411515\ \(0\)\
\-\ data\\:\\ 0\\.03235328277785775\ \(0\)\
\-\ touch\\:\\ 0\\.03235328277785775\ \(0\)\
\-\ successful\\:\\ 0\\.032022830714841063\ \(0\)\
\-\ prolonged\\:\\ 0\\.0319430868687776\ \(0\)\
\-\ lucent\\:\\ 0\\.03186442800670511\ \(0\)\
\-\ percutaneous\\:\\ 0\\.03178682500020651\ \(0\)\
\-\ useful\\:\\ 0\\.031486428229723334\ \(0\)\
\-\ treatment\\:\\ 0\\.03141915312284732\ \(0\)\
\-\ comparison\\:\\ 0\\.03141370604848622\ \(0\)\
\-\ 95\\:\\ 0\\.031270949729274695\ \(0\)\
\-\ choice\\:\\ 0\\.031270949729274695\ \(0\)\
\-\ minutes\\:\\ 0\\.03120087205697087\ \(0\)\
\-\ intense\\:\\ 0\\.031131633658411546\ \(0\)\
\-\ dose\\:\\ 0\\.030797359223567126\ \(0\)\
\-\ called\\:\\ 0\\.030797359223567126\ \(0\)\
\-\ needle\\:\\ 0\\.030605695134845165\ \(0\)\
\-\ within\\:\\ 0\\.03037808347964692\ \(0\)\
\-\ series\\:\\ 0\\.030240436601982033\ \(0\)\
\-\ has\\:\\ 0\\.030127556266879033\ \(0\)\
\-\ drug\\:\\ 0\\.030009152273627732\ \(0\)\
\-\ complaining\\:\\ 0\\.029841565548979265\ \(0\)\
\-\ options\\:\\ 0\\.02973248047916189\ \(0\)\
\-\ smaller\\:\\ 0\\.029678700210611045\ \(0\)\
\-\ containing\\:\\ 0\\.029625415619788358\ \(0\)\
\-\ highly\\:\\ 0\\.02952029750247509\ \(0\)\
\-\ larger\\:\\ 0\\.02952029750247509\ \(0\)\
\-\ potential\\:\\ 0\\.02946844659725897\ \(0\)\
\-\ margin\\:\\ 0\\.02892681922504468\ \(0\)\
\-\ major\\:\\ 0\\.02883356982962166\ \(0\)\
\-\ period\\:\\ 0\\.02883356982962166\ \(0\)\
\-\ 29\\:\\ 0\\.028741800645991616\ \(0\)\
\-\ oblique\\:\\ 0\\.028562520011387076\ \(0\)\
\-\ overlying\\:\\ 0\\.028096372330179354\ \(0\)\
\-\ sarcoma\\:\\ 0\\.027665021769397714\ \(0\)\
\-\ medications\\:\\ 0\\.027665021769397714\ \(0\)\
\-\ apparent\\:\\ 0\\.027589938413049638\ \(0\)\
\-\ under\\:\\ 0\\.027298992134542267\ \(0\)\
\-\ either\\:\\ 0\\.027263632163892108\ \(0\)\
\-\ facial\\:\\ 0\\.027193554491588282\ \(0\)\
\-\ young\\:\\ 0\\.027193554491588282\ \(0\)\
\-\ absent\\:\\ 0\\.02705589710304288\ \(0\)\
\-\ 100\\:\\ 0\\.02705589710304288\ \(0\)\
\-\ skull\\:\\ 0\\.026757653129895625\ \(0\)\
\-\ metastases\\:\\ 0\\.02666156221126054\ \(0\)\
\-\ before\\:\\ 0\\.02666156221126054\ \(0\)\
\-\ etiology\\:\\ 0\\.026567042331890237\ \(0\)\
\-\ bones\\:\\ 0\\.026535876018251903\ \(0\)\
\-\ general\\:\\ 0\\.026474042945642758\ \(0\)\
\-\ osseous\\:\\ 0\\.026322293100357\ \(0\)\
\-\ coronal\\:\\ 0\\.026262691158257773\ \(0\)\
\-\ occurs\\:\\ 0\\.02600183470824514\ \(0\)\
\-\ initially\\:\\ 0\\.025861843917514404\ \(0\)\
\-\ includes\\:\\ 0\\.02564467896182239\ \(0\)\
\-\ conservative\\:\\ 0\\.025461129031876382\ \(0\)\
\-\ sagittal\\:\\ 0\\.02535880180874179\ \(0\)\
\-\ uptake\\:\\ 0\\.02535880180874179\ \(0\)\
\-\ system\\:\\ 0\\.02515942559686535\ \(0\)\
\-\ pressure\\:\\ 0\\.025110637651815627\ \(0\)\
\-\ unknown\\:\\ 0\\.024990439202151018\ \(0\)\
\-\ rate\\:\\ 0\\.024990439202151018\ \(0\)\
\-\ used\\:\\ 0\\.024689139027153324\ \(0\)\
\-\ result\\:\\ 0\\.024689139027153324\ \(0\)\
\-\ second\\:\\ 0\\.024689139027153324\ \(0\)\
\-\ classic\\:\\ 0\\.024666599672371337\ \(0\)\
\-\ radiographic\\:\\ 0\\.024467604752312272\ \(0\)\
\-\ referred\\:\\ 0\\.024402766646416427\ \(0\)\
\-\ its\\:\\ 0\\.024402766646416427\ \(0\)\
\-\ commonly\\:\\ 0\\.024402766646416427\ \(0\)\
\-\ occur\\:\\ 0\\.024254247065232562\ \(0\)\
\-\ tumors\\:\\ 0\\.024254247065232562\ \(0\)\
\-\ defect\\:\\ 0\\.024191745514021888\ \(0\)\
\-\ tender\\:\\ 0\\.024109447509675735\ \(0\)\
\-\ laboratory\\:\\ 0\\.023948284818110826\ \(0\)\
\-\ involvement\\:\\ 0\\.023869357487433074\ \(0\)\
\-\ ap\\:\\ 0\\.023676628401530453\ \(0\)\
\-\ cortical\\:\\ 0\\.023676628401530453\ \(0\)\
\-\ dilated\\:\\ 0\\.023620040636418985\ \(0\)\
\-\ required\\:\\ 0\\.02354544170230747\ \(0\)\
\-\ sclerosis\\:\\ 0\\.02349011747936666\ \(0\)\
\-\ muscle\\:\\ 0\\.023417165884539366\ \(0\)\
\-\ girl\\:\\ 0\\.023134230543917694\ \(0\)\
\-\ was\\:\\ 0\\.022986912036421614\ \(0\)\
\-\ side\\:\\ 0\\.02278272409280195\ \(0\)\
\-\ presentation\\:\\ 0\\.022702090468025106\ \(0\)\
\-\ this\\:\\ 0\\.022664254087409262\ \(0\)\
\-\ benign\\:\\ 0\\.022654244645877956\ \(0\)\
\-\ neoplasm\\:\\ 0\\.022513038075282828\ \(0\)\
\-\ possible\\:\\ 0\\.022345008522923305\ \(0\)\
\-\ three\\:\\ 0\\.02213798200269373\ \(0\)\
\-\ initial\\:\\ 0\\.02212347424808226\ \(0\)\
\-\ back\\:\\ 0\\.021994517142862553\ \(0\)\
\-\ vascular\\:\\ 0\\.021772130603380933\ \(0\)\
\-\ positive\\:\\ 0\\.021731368950303205\ \(0\)\
\-\ patient\\:\\ 0\\.02145272919475982\ \(0\)\
\-\ superior\\:\\ 0\\.021440921077254243\ \(0\)\
\-\ any\\:\\ 0\\.021313573699785114\ \(0\)\
\-\ abscess\\:\\ 0\\.021176657270827886\ \(0\)\
\-\ onset\\:\\ 0\\.021176657270827886\ \(0\)\
\-\ clinical\\:\\ 0\\.020900445334553416\ \(0\)\
\-\ severe\\:\\ 0\\.020877039079186206\ \(0\)\
\-\ only\\:\\ 0\\.02060331519190356\ \(0\)\
\-\ treated\\:\\ 0\\.02053686230878181\ \(0\)\
\-\ changes\\:\\ 0\\.01993104220792354\ \(0\)\
\-\ abnormal\\:\\ 0\\.01981325197700076\ \(0\)\
\-\ focal\\:\\ 0\\.019726457962202886\ \(0\)\
\-\ lymphoma\\:\\ 0\\.019640947718692865\ \(0\)\
\-\ all\\:\\ 0\\.01963152418412258\ \(0\)\
\-\ two\\:\\ 0\\.019584635547714956\ \(0\)\
\-\ secondary\\:\\ 0\\.019547396532142422\ \(0\)\
\-\ shows\\:\\ 0\\.019355732443420457\ \(0\)\
\-\ been\\:\\ 0\\.01921385201803363\ \(0\)\
\-\ low\\:\\ 0\\.0189234431633871\ \(0\)\
\-\ one\\:\\ 0\\.01888194020568995\ \(0\)\
\-\ common\\:\\ 0\\.018702785845268074\ \(0\)\
\-\ mild\\:\\ 0\\.018694772902642518\ \(0\)\
\-\ symptoms\\:\\ 0\\.018044159025202944\ \(0\)\
\-\ physical\\:\\ 0\\.017881889977607143\ \(0\)\
\-\ acute\\:\\ 0\\.017840297444409285\ \(0\)\
\-\ imaging\\:\\ 0\\.017331502188402178\ \(0\)\
\-\ were\\:\\ 0\\.016999644670855938\ \(0\)\
\-\ mri\\:\\ 0\\.016928415796401985\ \(0\)\
\-\ present\\:\\ 0\\.016922519480563152\ \(0\)\
\-\ it\\:\\ 0\\.016881412796208195\ \(0\)\
\-\ large\\:\\ 0\\.016524041328248893\ \(0\)\
\-\ findings\\:\\ 0\\.01627638567067713\ \(0\)\
\-\ after\\:\\ 0\\.01599858115460657\ \(0\)\
\-\ well\\:\\ 0\\.015968522141420933\ \(0\)\
\-\ also\\:\\ 0\\.015512306276783057\ \(0\)\
\-\ which\\:\\ 0\\.014995811593961357\ \(0\)\
\-\ that\\:\\ 0\\.01431158449951146\ \(0\)\
\-\ as\\:\\ 0\\.013248774808059183\ \(0\)\
\-\ not\\:\\ 0\\.013019265820851186\ \(0\)\
\-\ left\\:\\ 0\\.011249805285043001\ \(0\)\
\-\ no\\:\\ 0\\.010724347030729232\ \(0\)\
\-\ year\\:\\ 0\\.010163432525965604\ \(0\)\
\-\ on\\:\\ 0\\.009960179021854877\ \(0\)\
\-\ old\\:\\ 0\\.009760413384404512\ \(0\)\
